Article
Evaluating the Overall Safety of Glucokinase Activators in Patients with Type 2 Diabetes…
Diabetes, Metabolic Syndrome and Obesity · 2024 · Liang TT, Cao MJ, Wang Q, Zou JS, Yang XM, Gu LF, Shi FH
Key facts
| Title | Evaluating the Overall Safety of Glucokinase Activators in Patients with Type 2 Diabetes Mellitus |
|---|---|
| First author | Liang TT, Cao MJ, Wang Q, Zou JS, Yang XM, Gu LF, Shi FH |
| Journal | Diabetes, Metabolic Syndrome and Obesity |
| Published | Nov 28, 2024 |
| DOI | 10.2147/DMSO.S474280 |
| Devices mentioned | 074401, 202101, 206191 |
At a glance
- 1–9 FDA submissions mentioned
- None Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1